Cagrisema (peptidedosingprotocols.com)

How it works

CagriSema combines cagrilintide and semaglutide to target overlapping signals that regulate appetite through different receptors. Cagrilintide is a long-acting amylin analogue that acts as a dual amylin and calcitonin receptor agonist (DACRA). Amylin is co-secreted with insulin after meals and plays a crucial role in enhancing meal-stop satiety, slowing gastric emptying, and suppressing post-meal glucagon release. The pharmacokinetics of cagrilintide, with a half-life of approximately 159–195 hours, supports its administration as a once-weekly injection.

Semaglutide, on the other hand, is a GLP-1 receptor agonist that is already FDA-approved for chronic weight management and type 2 diabetes. It reduces appetite, slows gastric emptying, and enhances glycemic control through glucose-dependent insulin secretion. The combination of cagrilintide and semaglutide is rationalized by their complementary mechanisms: while both compounds influence satiety and gastric emptying, they engage different receptor families, which allows for an additive effect rather than redundancy.

In the REDEFINE 1 trial, the combination of cagrilintide and semaglutide resulted in a mean weight loss of 20.4%, compared to 14.9% with semaglutide alone and 11.5% with cagrilintide alone, indicating that the dual action of these compounds is more effective in promoting weight loss than either compound used individually. This evidence supports the hypothesis that the two pathways work synergistically to enhance weight management outcomes in humans. [Source: Peptide Dosing Protocols]

Plain language: CagriSema works by combining two compounds that target different pathways in the body to help control appetite and promote weight loss.

Who should avoid it

Individuals with a history of gastrointestinal issues, those who are pregnant or breastfeeding, and patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid this stack. Additionally, caution is advised for those with a known allergy to any of the components. [Source: Peptide Dosing Protocols]

Plain language: People with certain health issues or allergies should not use this stack.